Search research articles
Contact Us
Filters
Showing results (51-60 of 121) with videos related to
Page
of 13
Sort By:
Bone Marrow Transplantation
|
January 1, 1996
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT)
F Frassoni, M Labopin, E Gluckman, et al.
British Journal of Haematology
|
February 13, 2001
Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?
O Ringdén, M Labopin, N C Gorin, et al.
Blood
|
November 14, 1997
Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow Transplantation
T De Witte, A Van Biezen, J Hermans, et al.
Leukemia
|
June 18, 2015
Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML)
A Pigneux, M Labopin, J Maertens, et al.
Bone Marrow Transplantation
|
May 29, 2007
Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies
C Ferry, G Gemayel, V Rocha, et al.
Bone Marrow Transplantation
|
April 9, 2014
Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT
T Czerw, M Labopin, N-C Gorin, et al.
Bone Marrow Transplantation
|
September 22, 2015
Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of ⩾10 years
G Andreola, M Labopin, D Beelen, et al.
Bone Marrow Transplantation
|
July 1, 1996
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)
N C Gorin, M Labopin, L Fouillard, et al.
Blood
|
November 5, 1997
Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
A Ferrant, M Labopin, F Frassoni, et al.
British Journal of Haematology
|
September 6, 2000
No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
J Y Cahn, M Labopin, J Sierra, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 121) with videos related to
Sort By:
Page
of 13
Bone Marrow Transplantation
|
January 1, 1996
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT)
F Frassoni, M Labopin, E Gluckman, et al.
British Journal of Haematology
|
February 13, 2001
Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?
O Ringdén, M Labopin, N C Gorin, et al.
Blood
|
November 14, 1997
Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow Transplantation
T De Witte, A Van Biezen, J Hermans, et al.
Leukemia
|
June 18, 2015
Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML)
A Pigneux, M Labopin, J Maertens, et al.
Bone Marrow Transplantation
|
May 29, 2007
Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies
C Ferry, G Gemayel, V Rocha, et al.
Bone Marrow Transplantation
|
April 9, 2014
Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT
T Czerw, M Labopin, N-C Gorin, et al.
Bone Marrow Transplantation
|
September 22, 2015
Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of ⩾10 years
G Andreola, M Labopin, D Beelen, et al.
Bone Marrow Transplantation
|
July 1, 1996
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)
N C Gorin, M Labopin, L Fouillard, et al.
Blood
|
November 5, 1997
Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
A Ferrant, M Labopin, F Frassoni, et al.
British Journal of Haematology
|
September 6, 2000
No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
J Y Cahn, M Labopin, J Sierra, et al.
Page
of 13